Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12451130 | 0.87 | EPHX1 (0.58) | ACHEALOX15 | |
| SCHEMBL19197809 | 0.86 | ALOX15 (0.39) | ACHEALOX15 | |
| SCHEMBL16325240 | 0.84 | ACHE (0.50) | ACHEALOX15 | |
| SCHEMBL1537776 | 0.84 | ACHE (0.54) | ACHEALOX15 | |
| SCHEMBL16298778 | 0.83 | EPHX1 (0.53) | ACHEALOX15 | |
| SCHEMBL12451127 | 0.81 | EPHX1 (0.54) | ACHEALOX15 | |
| SCHEMBL12451129 | 0.81 | EPHX1 (0.54) | ACHEALOX15 | |
| SCHEMBL12451125 | 0.81 | EPHX1 (0.54) | ACHEALOX15 | |
| SCHEMBL12451126 | 0.81 | EPHX1 (0.54) | ACHEALOX15 | |
| SCHEMBL7745030 | 0.80 | PRKCA (0.54) | ACHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240226004-A1 | FORMULATION AND AEROSOL CANISTERS, INHALERS, AND THE LIKE CONTAINING THE FORMULATION | JPMORGAN CHASE BANK, N.A. | 2024-07-11 | — | — | US | disclosed |
| US-20180071231-A1 | FORMULATION AND AEROSOL CANISTERS, INHALERS, AND THE LIKE CONTAINING THE FORMULATION | KINDEVA DRUG DELIVERY L.P. | 2018-03-15 | — | — | US | disclosed |
| US-20170292445-A1 | INTERNAL COMBUSTION ENGINE COMPONENTS WITH ANTI-FOULING PROPERTIES AND METHODS OF MAKING SAME | 3M INNOVATIVE PROPERTIES COMPANY | 2017-10-12 | — | — | US | disclosed |
| US-8815325-B2 | Medicinal inhalation device | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2014-08-26 | — | — | US | disclosed |
| US-8808786-B2 | Medicinal inhalation devices and components thereof | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2014-08-19 | — | — | US | disclosed |
| US-20130229378-A1 | OPTICAL DEVICE SURFACE TREATMENT PROCESS AND SMUDGE-RESISTANT ARTICLE PRODUCED THEREBY | 3M INNOVATIVE PROPERTIES COMPANY | 2013-09-05 | — | — | US | disclosed |
| US-20130220177-A1 | SURFACE TREATMENT PROCESS, COMPOSITION FOR USE THEREIN, AND TREATED ARTICLE | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2013-08-29 | — | — | US | disclosed |
| US-20130213395-A1 | MEDICINAL INHALATION DEVICES AND COMPONENTS THEREOF | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2013-08-22 | — | — | US | disclosed |
| US-8430097-B2 | Medicinal inhalation devices and components thereof | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2013-04-30 | — | — | US | disclosed |
| US-20120295119-A1 | METHOD OF MAKING COATED METAL ARTICLES | 3M INNOVATIVE PROPERTIES COMPANY | 2012-11-22 | — | — | US | disclosed |
| US-20120103330-A1 | MEDICINAL INHALATION DEVICE | 3M INNOVATIVE PROPERTIES COMPANY | 2012-05-03 | — | — | US | disclosed |
| US-20100263667-A1 | MEDICINAL INHALATION DEVICES AND COMPONENTS THEREOF | 3M INNOVATIVE PROPERTIES COMPANY | 2010-10-21 | — | — | US | disclosed |
| US-20100242958-A1 | MEDICINAL INHALATION DEVICES AND COMPONENTS THEREOF | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2010-09-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240226004-A1 | FORMULATION AND AEROSOL CANISTERS, INHALERS, AND THE LIKE CONTAINING THE FORMULATION | MCOLN3, SYMPK, ADRB2 | ACHE 879/4885ALOX15 428/4885 |
| US-20180071231-A1 | FORMULATION AND AEROSOL CANISTERS, INHALERS, AND THE LIKE CONTAINING THE FORMULATION | ADRB2, MCOLN3, ADRB1 | ACHE 286/4885ALOX15 511/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.